chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fingers being swollen his pinky thumb and his ring finger; Pink spots down his legs, arms and back.; Itchy; Rash now for two and a half months; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Fingers being swollen his pinky thumb and his ring finger), SKIN DISCOLOURATION (Pink spots down his legs, arms and back.), PRURITUS (Itchy) and RASH (Rash now for two and a half months) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus and Psoriasis.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In June 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced PERIPHERAL SWELLING (Fingers being swollen his pinky thumb and his ring finger), SKIN DISCOLOURATION (Pink spots down his legs, arms and back.), PRURITUS (Itchy) and RASH (Rash now for two and a half months). At the time of the report, PERIPHERAL SWELLING (Fingers being swollen his pinky thumb and his ring finger), SKIN DISCOLOURATION (Pink spots down his legs, arms and back.), PRURITUS (Itchy) and RASH (Rash now for two and a half months) had not resolved.            Additional concurrent medical condition included Sparkling Disposition. Concomitant medications was not provided by the reporter. Treatment information was not provided. First vaccine was given around the 05-MAY-2021 or 06-MAY-2021, patient was unsure of the exact date.Second vaccine was given around the 05-JUN-2021 or 06-JUN-2021, patient was unsure of the exact date. The patient had a rash now for two and a half months.  It started with his fingers being swollen his pinky thumb and his ring finger. He had pink spots down his legs, arms and back. It was worse, down his arms and hands. Itchy.
I was given my second dose of HPV vaccine today (4 days after my second dose of the moderna COVID vaccine)
Vaccine administered that went under temperature excursion of +1.9C to +6.4 C; Vaccine administered that went under temperature excursion of +1.9C to +6.4 C; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C) in an 80-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis.     Previously administered products included for Drug use for unknown indication: Pfizer (Dose 1) on 28-Jan-2021, PFIZER BIONTECH COVID-19 VACCINE (Dose 2) on 18-Feb-2021 and Pfizer (Dose 3) on 05-Oct-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, Pfizer and Pfizer.    On 15-Jun-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was stated that, the data logger was not set with correct parameter and excursion happened for 15 mins at the site + 1.9 Celsius (C).  The storage condition at the time of the excursion was refrigerator and maximum or minimum temperatures reached, as applicable was +1.9 C to +6.4C for 15 minutes. On 15-Jun-2022, the vial moved from freezer to refrigerator. At 09:15 am, the vial was initially punctured.  Vial was currently fridge quarantined in portal fridge.   The visual inspection noting any vaccine state change stated thawed. The proposed desired Use by Date was stated as afternoon.  No treatment medications were reported.
Feels like she is losing her voice; my voice keeps trying to go away; Date of 1st dose of vaccination: 24 Mar 2021/received their second dose of the COVID-19 Vaccine on Friday May 28th; This is a spontaneous report from a Pfizer-sponsored program.  A contactable consumer (patient) reported for herself that A 52-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: and Expiration date was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 27May2021 13:30 (at the age of 52-years-old) as 2ND DOSE, SINGLE for covid-19 immunisation. patient received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: ER8733 Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 24March 2021first dose single for covid-19 immunisation. Patient medical history included thyroid removed from Jan2012 to an unknown date Consumer stated, I have a thyroid problem, I got my thyroid removed; hypothyroidism Date of diagnosis of hypothyroidism: Consumer stated, It was sometimes in 2011 in September or October and it was removed in Jan of 2012.; Graves' disease and thyroiditis. Concomitant medication included levothyroxine taken for thyroid removed. patient states family medical history was not relevant to adverse event. Patient did not receive any other vaccines prior to the COVID vaccine. On an unspecified date patient experienced Feels like she is losing her voice; my voice keeps trying to go away was reported as worsened. Patient did not receive any medication. The patient underwent lab tests and procedures which included blood cholesterol and thyroid function test with unknown result on an unspecified date. Patient reported that she got a lot of lab test recently because she had been in the hospital. They did drug test, thyroid test they did my cholesterol. It was reported that event was persisting, it's worse than it was yesterday. patient states family medical history was not relevant to adverse event. The outcome of event feels like she is losing her voice; my voice keeps trying to go away was not recovered, while outcome of other event was unknown  Information on the lot/batch number has been requested.
child was given 3 doses of Rotarix/Extra Dose; This non-serious case was reported by a other health professional and described the occurrence of extra dose administered in a 6-month-old female patient who received Rota (Rotarix lyophilized formulation) (batch number 7LX33, expiry date 14-FEB-2024) for prophylaxis.   On 27-FEB-2023, the patient received the 3rd dose of Rotarix lyophilized formulation. On 27-FEB-2023, an unknown time after receiving Rotarix lyophilized formulation, the patient experienced extra dose administered (Verbatim: child was given 3 doses of Rotarix/Extra Dose). The outcome of the extra dose administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 12-OCT-2023 The patient was given 3 doses of Rotarix, which led to extra dose administered. This was 1 of 9 linked cases, reported by the same reporter.; Sender's Comments:  US-GSK-US2023130319:different patient same reporter US-GSK-US2023AMR142498:different patient same reporter US-GSK-US2023AMR142497:different patient same reporter US-GSK-US2023AMR142499:different patient same reporter US-GSK-US2023AMR142500:different patient same reporter US-GSK-US2023AMR142501:different patient same reporter US-GSK-US2023AMR142502:different patient same reporter US-GSK-US2023130319:different patient same reporter US-GSK-US2023AMR142512:different patient same reporter
Anaphylactic episode- 911 called, transported to the hospital.  Administration of PO Benadryl 50mg, IV Push  Benadryl 50mg,  epinephrine injection, IV Solu-Medrol, IV hydration.  Symptoms: difficulty breathing, swelling of throat and tongue, dizziness, nausea, rash/hives over entire upper body, rapid pulse, metallic taste in mouth.
Patient called on 12/8 to complain of persistent pain in the opposite arm (left) and jabbing eye pain almost immediately after her 2nd dose of shingrix, which was on 11/20. However, upon investigating her profile, I had noticed she had had her booster dose of Moderna covid vaccine in the left arm on  11/1. She has already been in contact with her physician, but she had called the pharmacy to see what our explanation may be.
10:00am T-dap administered; 13:30 p/c from patient informing Occ health of symptoms toungue/facial swelling - To ER SWG4 from home. 1400 EE left EE left ER 5 treatment by ER took Benadryl 50 by mouth at home
This case was reported by a sales representative and described the occurrence of crying in a 2-month-old subject of unspecified gender who was vaccinated with PEDIARIX (GlaxoSmithKline), INFANRIX (GlaxoSmithKline).  A physician or other health care professional has not verified this report.  On an unspecified date the subject received unspecified dose of PEDIARIX (unknown) or unspecified dose of INFANRIX (unknown). The reporter was not exactly sure that the vaccine administered to the subject was PEDIARIX.  It reportedly could have been INFANRIX.  At an unspecified time after vaccination with PEDIARIX or INFANRIX, the subject experienced crying.  It was indicated that the subject cried for 9 hours after vaccination, however, resolution was not specifically stated.
Mild fever; chills; diarrhea; joint pain; fatigue; injection site soreness; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 09Apr2021 at 14:00 as a single dose for COVID-19 immunisation. Medical history included atopy and allergy to penicillin and sulfa. Concomitant medications included vitamin c (MANUFACTURER UNKNOWN) and butchers broom (MANUFACTURER UNKNOWN), all from an unknown date for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the left arm on 19Mar2021 at 11:00 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Apr2021 at 11:00, the patient experienced mild fever, chills, diarrhea, joint pain, fatigue and injection site soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events mild fever, chills, diarrhea, joint pain, fatigue and injection site soreness were recovered on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
I received my period 2 weeks early (15 days after my last period). This is highly unusual for my cycle.
Initial misuse report received from a healthcare professional on 04 April 2013. A 17-month-old patient received DAPTACEL subcutaneously instead of intramuscularly. No adverse event was reported. List of documents held by sender: none.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. In November 2010, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), at a hospital as recommended by his physician for the long-term prevention of shingle and as preventative measure prior to having surgery. The ZOSTAVAX did not prevent shingles as intended. Instead the patient contracted a persistent strain of shingles, or herpes zoster. In approximately July 2016, the patient was treated by a physician for the onset of herpes zoster or shingles. As a direct and proximate result of the defective ZOSTAVAX, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. The outcome of the events is unknown. Additional information has been requested.
At the time of injection, it was pretty painful and thus sent my body into a shock less than 5 mins after receiving my dose. My vision went white and I was very light-headed and hot/sweaty.  A nurse came with me outside to monitor and I was feeling back to normal in 15 minutes. This is something that happens when I experience a high amount of pain, so just reporting for others who maybe have low blood pressure issues.  At about 8pm, other side effects started to set in. I first experienced a headache, then experienced soreness/ache-y-ness  in my back. Around 8:30, I started to feel light headed again and soon my whole body felt ache-y. I quickly developed chills where I felt so cold that I was uncontrollably shaking and felt very sore/stiff. I have been laying under a heated blanket for the last hour and a half and am finally feeling better with no more shaking  or chills. I still have soreness throughout my body and a headache, but I took ibuprofen around 8:30pm.
sore arm; A spontaneous report was received from a Consumer concerning a 31-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 15 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 013L20A) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced sore arm.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, sore arm was Unknown.; Reporter's Comments: This case concerns a 31-year-old female with a NS unexpected event of Pain in extremity.  Event onset occurred with unknown latency after the first dose of mRNA-1273. Treatment not reported. Event outcome unknown. Based on the current available information and temporal association between use of the product and the start date of the events, a causal relationship cannot be excluded.
6 x 8cm light red, slightly warm area to upper right arm with a "tail" of redness. Prescribed Duricef for 10 days and Benadryl PRN.
local Reaction left arm, 50 cent size swelling on right deltoid, no drainage, some overlying
pain at touch in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at touch in the injection site) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain at touch in the injection site). At the time of the report, VACCINATION SITE PAIN (pain at touch in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. No treatment information provided.   This case was linked to MOD-2021-070213 (Patient Link).
Noticed a bump on patient's left shoulder by the neck about a week after her first vaccine injection. It slowly started to dissipate after almost two weeks but was still slightly visible. Her pediatrician examined her and informed us this was a reaction to the vaccine and to report this via this link.
Had a sore throat, then a runny nose, was very tired,  but no fever. Used a rapid home test. It was positive. Called Dr.  He prescribed Paxlovid. Took the Med. Symptoms stopped the next day. Masked and isolated self for five days. felt fine. After one week tested negative. Have had no symptoms since that time.
Information was received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about 21-SEP-2016, the patient was vaccinated at a physician's office with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 19-OCT-2016, the patient was treated by a physician for onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages.  Additional information has been requested.
lymph nodes under my arm are swollen; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph nodes under my arm are swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (lymph nodes under my arm are swollen). At the time of the report, LYMPHADENOPATHY (lymph nodes under my arm are swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not provided. No treatment information was provided by the reporter.
pt recv 1st dose of vax;devel flu-like sx w/ fatigue & a cold,sl rash on rt wrist;recv 2nd dose & became ill;to MD 16mar94;rash w/ pruritus;was warm to the touch on both eyelids;brow bright red;felt tired;fatigue & allergic dermatitis;
Mild case of shingles on left side, went to Dr office received VALTREX 1mg 1 bid x 7 days and LORTABS # 30 1-2 q 6 hours.
Information has been received from a other health professional referring to a male patient of unknown age. No medical history, concurrent conditions or concomitant therapies were reported. An unspecified date in 2009, the patient was vaccinated with ZOSTAVAX, 19400 DF (Dose, lot number, expiration date and administration route were not provided). On an unspecified date, reported as "recently", the patient experienced shingles lasting an unspecified duration of time. At the time of reporting, the outcome of shingles was unknown. The causal relationship between therapy with ZOSTAVAX and the shingles was unknown. No product quality complaint (PQC) was involved. Additional information has been requested.
Started about 20 minutes after injection. It started out very similar to when you hit your funny bone.. and it went throughout my arm. Then I started to feel heat building on that side. Definitely at the injection site (expecting that) but then it started to REALLY build in my arm pit. By the time I got home (28 min drive) I had a full blown flare. At first I didn't think anything of it. I knew my immune system was going to take a hit which was going to mess with my condition but I had no idea it would be to THIS extent. After a week and I was able to lift my arm a little and proceed to drain my flares - I have INTENSE red/purple discoloration and I am draining from about 4 different places (I did not poke/lance, they started draining on their own).   I also had (and still have) localized heat at the injection site. Up until a few days ago, I had a large knot and the red/heat was growing in diameter. At it's peak, reached about 3.5-4 inches. The red did dissipate but the heat did not. That is still present  I have pictures depicting all of this.
3 days after dose 2 vaccine, I started having muscle cramps in lower back and nerve pain shooting into left hip and leg. I was also nauseated possibly due to the pain. The intensity increased over the night and into the next day so I went into the walk in clinic on 7-29. They did not order any tests or labs because he felt it could be a delayed reaction to the vaccine. He prescribed a muscle relaxer but I did not take any and just took TYLENOL. On 7-30 I had to go back to the walk in clinic because I was having vertigo if I turned my head to look in any direction other than straight ahead. The doctor just did a physical workup in the office and also stated these symptoms were likely due to the vaccine. On 7-31, I had a squeezing and burning sensation in my head. Today, 8-1, I feel better but I am having muscle twitching all over. I had COVID19 back in March 2021, and 4-5 months later, I did have muscle twitching at the time and was told by a doctor that I am a long COVID19 sufferer.
Pt called stating low grade fever through the night.  States redness and swelling by the injection site, warm to touch.  Also states pain down to the elbow of her left hand.  Discussed Motrin and compresses to site also to follow up with physician.  At this time client was not going to follow up due to no insurance.
Chills Sweating Nausea Headache Body aches Fatigue Redness and itchiness at injection site 9 days after injection
SUNDAY NIGHT PATIENT BEGAN FEELING SOME ITCHING AND SWELLING AROUND ADMINISTRATION SITE. THE MORNING OF 9/14 PATIENT NOTICED RED AREA WITH SWELLING AROUND IT. PATIENT CALLED DOCTOR ON 9/14 EARLY AFTERNOON, WAS ADVISED TO DRAW RED CIRCLE AROUND SPOT. THE SPOT HAS DECREASED IN REDNESS BUT HAS SWOLLEN FURTHER AROUND THE AREA. PATIENT HAS TAKEN ZYRTEC BUT NO OTHER MEDICATIONS.